Boston, Massachusetts
Alzheimer's disease clinical trials in Boston, MA
27 Alzheimer's disease studies are recruiting participants at sites in Boston as of November 16, 2026, according to ClinicalTrials.gov. Clinical Trials for Alzheimer's Disease can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Boston at a glance
- 27 studies are recruiting at a site in Boston.
- By phase: Early Phase 1 (1), Phase 1 (1), Phase 1/2 (2), Phase 2 (5), Phase 3 (4), No phase (8), Observational (6). Studies of devices and behavioral approaches have no phase.
- By sponsor: university, hospital or other (18), industry (7), government (2).
- Most recent update to one of these records: November 16, 2026.
Studies recruiting in Boston
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Contributions of mTBI to Neurodegeneration Due to Chronic Traumatic Encephalopathy (CTE) and Alzheimer's Disease (AD)
- Observational
- Ages 30 to 90
- All sexes
- Sponsor
- VA Office of Research and Development
- Study site
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA
- Registry record
- NCT04124029 · updated
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Phase 3
- Ages 50 to 90
- All sexes
- Sponsor
- Hoffmann-La Roche
- Study site
- Adams Clinical Boston
- Registry record
- NCT07177352 · updated
A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease
- Phase 3
- Ages 55 to 80
- All sexes
- Sponsor
- Hoffmann-La Roche
- Study site
- Adams Clinical Boston
- Registry record
- NCT07717411 · updated
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia
- Phase 2
- Ages 55 and older
- All sexes
- Sponsor
- Intra-Cellular Therapies, Inc.
- Study site
- Tufts University School of Medicine
- Registry record
- NCT06651567 · updated
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Phase 3
- Ages 55 to 90
- All sexes
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Study site
- Tufts Medical Center - 800 Washington St - PPDS
- Registry record
- NCT06585787 · updated
Alzheimer's Tau Platform: Master Protocol
- Phase 2
- Ages 50 to 80
- All sexes
- Sponsor
- Paul S. Aisen
- Study site
- Brigham and Women's Hospital Center for Alzheimer Research and Treatment
- Registry record
- NCT06957418 · updated
Biomarker-based Trial of NPC-1 for Alzheimer's Pathology
- Phase 2
- Ages 55 and older
- All sexes
- Sponsor
- Massachusetts General Hospital
- Study site
- Massachusetts General Hospital
- Registry record
- NCT07236190 · updated
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- Phase 2
- Ages 55 to 80
- All sexes
- Sponsor
- Lighthouse Pharmaceuticals, Inc.
- Study site
- Adams Clinical Boston
- Registry record
- NCT06847321 · updated
Dominantly Inherited Alzheimer Network (DIAN)
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- Washington University School of Medicine
- Study site
- Brigham and Women's Hospital
- Registry record
- NCT00869817 · updated
Improving Memory in Alzheimer's Disease With Noninvasive Brain Stimulation
- No phase
- Ages 50 to 100
- All sexes
- Sponsor
- Boston University Charles River Campus
- Study site
- 111 Cummington Mall. Room 264
- Registry record
- NCT06094192 · updated
Tau PET/CT Imaging in the Mismatch Prospective Cohort Study (MPC-TAU)
- Observational
- Ages 18 to 120
- All sexes
- Sponsor
- University of Pennsylvania
- Study site
- Massachusetts General Hospital
- Registry record
- NCT05658913 · updated
Use of a Mobile Brain-Body Imaging Approach to Evaluate the Effects of Rhythmic Auditory Stimulation on Gait and Brain Function in Alzheimer's Disease
- No phase
- Ages 50 to 90
- All sexes
- Sponsor
- Boston University Charles River Campus
- Study site
- Boston University Neuromotor Recovery Laboratory
- Registry record
- NCT07659964 · updated
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Eidos Therapeutics, a BridgeBio company
- Study sites
- Boston University (BU) School of Medicine · Brigham and Women's Hospital · Massachusetts General Hospital
- Registry record
- NCT06563895 · updated
Gamma Light and Sound Stimulation to Prevent Dementia in Cognitively Normal People at Risk for Alzheimer's Disease
- No phase
- Ages 55 to 90
- All sexes
- Sponsor
- Massachusetts General Hospital
- Study site
- Massachusetts General Hospital
- Registry record
- NCT05776641 · updated
Trial-Ready Cohort-Down Syndrome (TRC-DS)
- Observational
- Ages 25 to 55
- All sexes
- Sponsor
- University of Southern California
- Study site
- Massachusetts General Hospital, Co-Enrolling through ABC-DS Only
- Registry record
- NCT04165109 · updated
Transcranial Magnetic Stimulation Treatment for Alzheimer's Disease
- Early Phase 1
- Ages 40 to 99
- All sexes
- Sponsor
- Massachusetts General Hospital
- Study site
- Massachusetts General Hospital
- Registry record
- NCT06538311 · updated
Cognitive Neurology Unit Clinical Registry
- Observational
- Ages 50 to 95
- All sexes
- Sponsor
- Beth Israel Deaconess Medical Center
- Study site
- Beth Israel Deaconess Medical Center
- Registry record
- NCT05925621 · updated
Digital Accessible Remote Olfactory Mediated Health Assessments for Preclinical AD
- Observational
- Ages 18 to 100
- All sexes
- Sponsor
- Massachusetts General Hospital
- Study site
- Massachusetts General Hospital
- Registry record
- NCT05881239 · updated
TMS for Cognitive Decline in Aging and Preclinical AD
- No phase
- Ages 40 to 99
- All sexes
- Sponsor
- Massachusetts General Hospital
- Study site
- Massachusetts General Hospital
- Registry record
- NCT06956300 · updated
Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease
- Phase 2
- Ages 60 to 85
- All sexes
- Sponsor
- Brigham and Women's Hospital
- Study site
- Center for Alzheimer Research and Treatment, Brigham and Women's Hospital
- Registry record
- NCT06489548 · updated
PET Brain Imaging in Multiple Sclerosis, Alzheimer's Disease, and Other Neurological and Neuropsychiatric Diseases
- Phase 1/2
- Ages 18 to 85
- All sexes
- Sponsor
- Brigham and Women's Hospital
- Study site
- Brigham MS Center, 60 Fenwood Road
- Registry record
- NCT02649985 · updated
Non-invasive Brain Stimulation for Cognitive and Motor Dysfunction in Dementia
- No phase
- Ages 55 and older
- All sexes
- Sponsor
- Hebrew SeniorLife
- Study site
- Hinda and Arthur Marcus Institute for Aging Research
- Registry record
- NCT05661084 · updated
Trial to Reduce Antimicrobial Use in Nursing Home Residents With Alzheimer's Disease and Other Dementias 2.0
- No phase
- Ages 60 to 106
- All sexes
- Sponsor
- Hebrew SeniorLife
- Study site
- Hebrew SeniorLife
- Registry record
- NCT05950607 · updated
Assess Fibrin in Brains With AD/ADRD
- Phase 1/2
- Ages 55 to 90
- All sexes
- Sponsor
- Massachusetts General Hospital
- Study site
- Massachusetts General Hospital
- Registry record
- NCT05336695 · updated
Exploratory Clinical Study to Assess Safety and Efficacy of Xenon Gas Inhalation to Control Neuroinflammation
- Phase 1
- Ages 55 to 75
- All sexes
- Sponsor
- General Biophysics LLC
- Study site
- Brigham and Women's Hospital
- Registry record
- NCT06945614 · updated
Mindfulness for Cognition in Early-stage Alzheimer's Disease
- No phase
- Ages 50 to 100
- All sexes
- Sponsor
- VA Boston Healthcare System
- Study site
- VA Boston Healthcare System - Jamaica Plain Campus
- Registry record
- NCT06792877 · updated
Gamma-Music Based Intervention for Mild Alzheimer's Disease
- No phase
- Ages 50 to 95
- All sexes
- Sponsor
- Northeastern University
- Study site
- Northeastern University
- Registry record
- NCT05984524 · updated
Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in Boston, MA on ClinicalTrials.gov.
Ask about studies near Boston
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
More locations in Massachusetts
All Massachusetts locations
48 studies recruiting across 17 cities.
Newton
8 studies recruiting.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Clinical Trials for Alzheimer's Disease does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections